OverviewLenalidomide Mylan is a medicine used for the treatment of certain cancers affecting blood cells, namely multiple myeloma and follicular lymphoma.In multiple myeloma,...
OverviewThis is a summary of the European public assessment report (EPAR) for Efavirenz/Emtricitabine/Tenofovir disoproxil Zentiva. It explains how the Agency assessed the medicine...
OverviewThis is a summary of the European public assessment report (EPAR) for Uptravi. It explains how the Agency assessed the medicine to recommend...
OverviewThis is a summary of the European public assessment report (EPAR) for Skilarence. It explains how the Agency assessed the medicine to recommend...
OverviewThis is a summary of the European public assessment report (EPAR) for Aerius. It explains how the Committee for Medicinal Products for Human...
OverviewThis is a summary of the European public assessment report (EPAR) for Azomyr. It explains how the Committee for Medicinal Products for Human...
OverviewThis is a summary of the European public assessment report (EPAR) for Neoclarityn. It explains how the Committee for Medicinal Products for Human...
OverviewThis is a summary of the European public assessment report (EPAR) for Benepali. It explains how the Agency assessed the medicine to recommend...
OverviewGencebok is a stimulant medicine used for treating apnoea of prematurity, a condition in which babies born prematurely stop breathing for longer than...
OverviewImcivree is a medicine used to treat obesity and help control hunger caused by certain genetic conditions that affect how the brain controls...
OverviewThis is a summary of the European public assessment report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP)...
At its monthly meeting, EMA’s safety committee (PRAC) carried out its broad range of responsibilities, which cover all aspects of the risk management...
EMA has recommended the approval of Hepizovac, the first vaccine against epizootic haemorrhagic disease (EHD) authorised in the EU for use in cattle....
OverviewKoselugo is a medicine used to treat plexiform neurofibromas, benign (non-cancerous) tumours along the nerves, when they cause symptoms and cannot be removed...